156 related articles for article (PubMed ID: 12869654)
1. Polymorphisms in human soluble epoxide hydrolase.
Przybyla-Zawislak BD; Srivastava PK; Vazquez-Matias J; Mohrenweiser HW; Maxwell JE; Hammock BD; Bradbury JA; Enayetallah AE; Zeldin DC; Grant DF
Mol Pharmacol; 2003 Aug; 64(2):482-90. PubMed ID: 12869654
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure.
Srivastava PK; Sharma VK; Kalonia DS; Grant DF
Arch Biochem Biophys; 2004 Jul; 427(2):164-9. PubMed ID: 15196990
[TBL] [Abstract][Full Text] [Related]
3. Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis.
Enayetallah AE; Grant DF
Biochem Biophys Res Commun; 2006 Mar; 341(1):254-60. PubMed ID: 16414022
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury.
Koerner IP; Jacks R; DeBarber AE; Koop D; Mao P; Grant DF; Alkayed NJ
J Neurosci; 2007 Apr; 27(17):4642-9. PubMed ID: 17460077
[TBL] [Abstract][Full Text] [Related]
5. Variability in human sensitivity to 1,3-butadiene: Influence of the allelic variants of the microsomal epoxide hydrolase gene.
Abdel-Rahman SZ; El-Zein RA; Ammenheuser MM; Yang Z; Stock TH; Morandi M; Ward JB
Environ Mol Mutagen; 2003; 41(2):140-6. PubMed ID: 12605384
[TBL] [Abstract][Full Text] [Related]
6. Expression of the human soluble epoxide hydrolase in Escherichia coli by auto-induction for the study of high-throughput inhibition assays.
Nishi K; Kim IH; Ma SJ
Protein Expr Purif; 2010 Jan; 69(1):34-8. PubMed ID: 19782755
[TBL] [Abstract][Full Text] [Related]
7. Seventy genetic variations in human microsomal and soluble epoxide hydrolase genes (EPHX1 and EPHX2) in the Japanese population.
Saito S; Iida A; Sekine A; Eguchi C; Miura Y; Nakamura Y
J Hum Genet; 2001; 46(6):325-9. PubMed ID: 11393535
[TBL] [Abstract][Full Text] [Related]
8. Cloning of an epoxide hydrolase-encoding gene from Aspergillus niger M200, overexpression in E. coli, and modification of activity and enantioselectivity of the enzyme by protein engineering.
Kotik M; Stepánek V; Kyslík P; Maresová H
J Biotechnol; 2007 Oct; 132(1):8-15. PubMed ID: 17875334
[TBL] [Abstract][Full Text] [Related]
9. Measurement and characterization of membrane-bound and soluble epoxide hydrolase activities in resting mononuclear leukocytes from human blood.
Seidegård J; DePierre JW; Pero RW
Cancer Res; 1984 Sep; 44(9):3654-60. PubMed ID: 6744285
[TBL] [Abstract][Full Text] [Related]
10. Theoretical study of the full reaction mechanism of human soluble epoxide hydrolase.
Hopmann KH; Himo F
Chemistry; 2006 Sep; 12(26):6898-909. PubMed ID: 16856182
[TBL] [Abstract][Full Text] [Related]
11. Improved radiolabeled substrates for soluble epoxide hydrolase.
Borhan B; Mebrahtu T; Nazarian S; Kurth MJ; Hammock BD
Anal Biochem; 1995 Oct; 231(1):188-200. PubMed ID: 8678300
[TBL] [Abstract][Full Text] [Related]
12. Cloning, expression, purification, and characterization of a novel epoxide hydrolase from Aspergillus niger SQ-6.
Liu Y; Wu S; Wang J; Yang L; Sun W
Protein Expr Purif; 2007 Jun; 53(2):239-46. PubMed ID: 17317214
[TBL] [Abstract][Full Text] [Related]
13. Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients.
Ohtoshi K; Kaneto H; Node K; Nakamura Y; Shiraiwa T; Matsuhisa M; Yamasaki Y
Biochem Biophys Res Commun; 2005 May; 331(1):347-50. PubMed ID: 15845398
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification, and characterisation of human soluble Epoxide Hydrolase (hsEH) and of its functional C-terminal domain.
Abis G; Charles RL; Eaton P; Conte MR
Protein Expr Purif; 2019 Jan; 153():105-113. PubMed ID: 30218745
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues.
Enayetallah AE; French RA; Barber M; Grant DF
J Histochem Cytochem; 2006 Mar; 54(3):329-35. PubMed ID: 16314446
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.
Imig JD
Cardiovasc Drug Rev; 2006; 24(2):169-88. PubMed ID: 16961727
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
18. Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans.
Ramirez CE; Shuey MM; Milne GL; Gilbert K; Hui N; Yu C; Luther JM; Brown NJ
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():38-44. PubMed ID: 25173047
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of styrene-7,8-oxide in human liver in vitro: interindividual variation and stereochemistry.
Wenker MA; Kezić S; Monster AC; de Wolff FA
Toxicol Appl Pharmacol; 2000 Nov; 169(1):52-8. PubMed ID: 11076696
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase and ischemic cardiomyopathy.
Zhao TT; Wasti B; Xu DY; Shen L; Du JQ; Zhao SP
Int J Cardiol; 2012 Mar; 155(2):181-7. PubMed ID: 21704394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
